Literature DB >> 11096497

Ventricular Septal Defect.

.   

Abstract

Ventricular septal defects (VSDs) are the most common congenital heart malformations seen in children. Because spontaneous closure occurs frequently, patients with small VSDs should be followed clinically with no limitations except endocarditis prophylaxis. Surgical closure is recommended for only small defects with significant associated lesions such as aortic regurgitation, aortic valve prolapse, right or left ventricular outflow obstruction, tricuspid regurgitation, left ventricle to right atrial shunt, or recurrent endocarditis. Enlarging left ventricular size or deteriorating left ventricular function would also be an indication for surgical repair. Moderate and large VSDs in infancy often require treatment of congestive heart failure with diuretics, digitalis, and afterload reduction. Surgical closure before 9 months of age is indicated for large VSDs and by 2 years of age for moderate shunts to prevent pulmonary vascular obstructive disease and the consequences of long-standing volume overload. Device closure of VSD is still in the investigational stage but holds promise for treatment of apical or multiple muscular VSDs.

Entities:  

Year:  1999        PMID: 11096497     DOI: 10.1007/s11936-999-0026-4

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  32 in total

1.  Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease.

Authors:  D D Ivy; J P Kinsella; J W Ziegler; S H Abman
Journal:  J Thorac Cardiovasc Surg       Date:  1998-04       Impact factor: 5.209

2.  Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease.

Authors:  M Berner; M Beghetti; I Spahr-Schopfer; I Oberhansli; B Friedli
Journal:  Am J Cardiol       Date:  1996-03-01       Impact factor: 2.778

Review 3.  26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 1: congenital heart disease.

Authors:  T P Graham; J T Bricker; F W James; W B Strong
Journal:  J Am Coll Cardiol       Date:  1994-10       Impact factor: 24.094

4.  Ventricular septal defect.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1981-12-18       Impact factor: 17.586

5.  Preoperative transcatheter closure of congenital muscular ventricular septal defects.

Authors:  N D Bridges; S B Perry; J F Keane; S A Goldstein; V Mandell; J E Mayer; R A Jonas; A R Casteneda; J E Lock
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

6.  Minimally invasive cardiac surgical techniques in the closure of ventricular septal defect: an alternative approach.

Authors:  P J Lin; C H Chang; J J Chu; H P Liu; F C Tsai; W J Su; M W Yang; P P Tan
Journal:  Ann Thorac Surg       Date:  1998-01       Impact factor: 4.330

7.  Results of 102 cases of complete repair of congenital heart defects in patients weighing 700 to 2500 grams.

Authors:  V M Reddy; D B McElhinney; T Sagrado; A J Parry; D F Teitel; F L Hanley
Journal:  J Thorac Cardiovasc Surg       Date:  1999-02       Impact factor: 5.209

8.  Intraoperative device closure of ventricular septal defects.

Authors:  S B Fishberger; N D Bridges; J F Keane; F L Hanley; R A Jonas; J E Mayer; A R Castaneda; J E Lock
Journal:  Circulation       Date:  1993-11       Impact factor: 29.690

9.  Management and outcome of low birth weight neonates with congenital heart disease.

Authors:  A C Chang; F L Hanley; J E Lock; A R Castaneda; D L Wessel
Journal:  J Pediatr       Date:  1994-03       Impact factor: 4.406

10.  Occurrence risk for congenital heart defects in relatives of patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect.

Authors:  D J Driscoll; V V Michels; W M Gersony; C J Hayes; J F Keane; L Kidd; D R Pieroni; L J Rings; R R Wolfe; W H Weidman
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

View more
  4 in total

Review 1.  Surgical management of muscular trabecular ventricular septal defects.

Authors:  Toshihide Asou
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-11-15

2.  Association between ISL1 variants and susceptibility to ventricular septal defect in a Chinese cohort.

Authors:  Jilu Lang; Weichen Tian; Xian Sun
Journal:  Mol Diagn Ther       Date:  2013-04       Impact factor: 4.074

3.  A new scoring system for spontaneous closure prediction of perimembranous ventricular septal defects in children.

Authors:  Jing Sun; Kun Sun; Sun Chen; Liping Yao; Yuqi Zhang
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

4.  Prediction of spontaneous closure of ventricular septal defect and guidance for clinical follow-up.

Authors:  Xinyang Li; Weidong Ren; Guang Song; Xintong Zhang
Journal:  Clin Cardiol       Date:  2019-03-25       Impact factor: 2.882

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.